Download PDF
Thromb Haemost 2004; 92(04): 672-673
DOI: 10.1160/TH04-08-0472
Editorial Focus
Schattauer GmbH

Paracetamol (acetaminophen) and warfarin interaction: unraveling the pivotal role of the vitamin K cycle

Elaine M. Hylek
1   Boston University School of Medicine, Department of Medicine, Section of General Internal Medicine and the Clinical Epidemiology Unit, Boston, Massachusetts, USA
› Author Affiliations
Further Information

Publication History

Received 04 August 2004

Accepted after revision 11 August 2004

Publication Date:
06 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Shorr RI, Ray WA, Daugherty JR. et al. Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease. Arch Intern Med 1993; 153: 1665-9.
    CrossrefPubMedGoogle Scholar
  • 2 Antlitz AM, Mead JA, Tolentino MA. Potentiation of oral anticoagulant therapy by acetaminophen. Curr Ther Res 1968; 10: 501-7.
    PubMedGoogle Scholar
  • 3 Hylek EM, Heiman H, Skates SJ. et al. Acetaminophen and other risk factors for excessive warfarin anticoagulation. JAMA 1998; 279: 657-62.
    CrossrefPubMedGoogle Scholar
  • 4 Fattinger K, Frisullo R, Masche U. et al. No clinically relevant drug interaction between paracetamol and phenprocoumon based on a pharmacoepidemiological cohort study in medical patients. Eur J Clin Pharmacol 2002; 57: 863-7.
    CrossrefPubMedGoogle Scholar
  • 5 Gadisseur AP, van der Meer FJ, Rosendaal Fr. Sustained intake of paracetamol (acetaminophen) during oral anticoagulant therapy with coumarins does not cause clinically important INR changes: a randomized double-blind clinical trial. Thromb Haemost 2003; 01: 714-7.
    CrossrefPubMedGoogle Scholar
  • 6 Kwan D, Bartle WR, Walker SE. The effects of acetaminophen on pharmacokinetics and pharmacodynamics of warfarin. J Clin Pharmacol 1999; 39: 68-75.
    CrossrefPubMedGoogle Scholar
  • 7 Whyte IM, Buckley NA, Reith DM. et al. Acetaminophen causes an increased international normalized ratio by reducing functional factor VII. Ther Drug Monit 2000; 22: 742-8.
    CrossrefPubMedGoogle Scholar
  • 8 Ansell J, Hirsch J, Poller L. et al. The pharmacology and management of the vitamin K antagonists. Chest. 2004 126. in press.
    PubMedGoogle Scholar
  • 9 Thijssen HH, Soute BA, Vervoort LM. et al. Paracetamol (acetaminophen) warfarin interaction. NAPQI, the toxic metabolite of paracetamol, is an inhibitor of enzymes of the vitamin K cycle. Thromb Haemost 2004; 92: 797-82.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Loguercio C, Taranto D, Vitale LM. et al. Effect of liver cirrhosis and age on the glutathione concentration in the plasma, erythrocytes, and gastric mucosa of man. Free Rad Biol Med 1996; 20: 483-8.
    CrossrefPubMedGoogle Scholar
  • 11 Julius M, Lang CA, Gleiberman L. et al. Glutathione and morbidity in a communitybased sample of elderly. J Clin Epidemiol 1994; 47: 1021-6.
    CrossrefPubMedGoogle Scholar
  • 12 Nuttall SL, Martin U, Sinclair AJ. et al. Glutathione: In sickness and in health. Lancet 1998; 351: 645-6.
    CrossrefPubMedGoogle Scholar